Moreover, studies indicate that YAP1 expression in SCLC-Y cell lines, enriched with SMARCA4 mutations, exhibits characteristics of SMARCA4-deficient malignancies rather than traditional SCLC (22). The gene discussed is SMARCA4; the disease is small cell lung carcinoma.